BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16555058)

  • 1. Mechanism of action differences in the antitumor effects of transmembrane and secretory tumor necrosis factor-alpha in vitro and in vivo.
    Li Q; Li L; Shi W; Jiang X; Xu Y; Gong F; Zhou M; Edwards CK; Li Z
    Cancer Immunol Immunother; 2006 Dec; 55(12):1470-9. PubMed ID: 16555058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfected mouse mammary tumor.
    Matory YL; Dorfman DM; Wu L; Chen M; Goedegebuure P; Eberlein TJ
    Pathobiology; 1999; 67(4):186-95. PubMed ID: 10738180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of the fibroblasts transfected TNF-alpha gene and its mutants.
    Li Q; Li L; Li Z; Gong F; Feng W; Jiang X; Xiong P
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):92-5. PubMed ID: 12658742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo.
    Mueller C; Corazza N; Trachsel-Løseth S; Eugster HP; Bühler-Jungo M; Brunner T; Imboden MA
    J Biol Chem; 1999 Dec; 274(53):38112-8. PubMed ID: 10608881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral vector-mediated transfer of the tumor necrosis factor alpha gene into human cancer cells restores an apoptotic cell death program and induces a bystander-killing effect.
    Gillio Tos A; Cignetti A; Rovera G; Foa R
    Blood; 1996 Mar; 87(6):2486-95. PubMed ID: 8630415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effector function of CD4-independent, CD8(+) T cells is mediated by TNF-α/TNFR.
    Zimmerer JM; Horne PH; Fiessinger LA; Fisher MG; Pham TA; Saklayen SL; Bumgardner GL
    Transplantation; 2012 Dec; 94(11):1103-10. PubMed ID: 23222736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel co-culture assay to assess anti-tumor CD8
    Olivo Pimentel V; Yaromina A; Marcus D; Dubois LJ; Lambin P
    J Immunol Methods; 2020 Dec; 487():112899. PubMed ID: 33068606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
    Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
    Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes.
    Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP
    Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of a tumor cell vaccine expressing a membrane-bound form of the IL-12 p35 subunit.
    Lim HY; Ju HY; Chung HY; Kim YS
    Cancer Biol Ther; 2010 Aug; 10(4):336-43. PubMed ID: 20534980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
    Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
    J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.
    Huang H; Li F; Gordon JR; Xiang J
    Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells.
    Alosco T; Croy BA; Gansbacher B; Wang HQ; Rao U; Bankert R
    Cancer Immunol Immunother; 1993 Jun; 36(6):364-72. PubMed ID: 8500109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.
    Melgar S; Bas A; Hammarström S; Hammarström ML
    Immunology; 2002 Aug; 106(4):476-85. PubMed ID: 12153510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
    Ye Z; Shi M; Chan T; Sas S; Xu S; Xiang J
    Cancer Gene Ther; 2007 Jul; 14(7):661-75. PubMed ID: 17479109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
    Xiang J; Chen Y; Moyana T
    Cancer Gene Ther; 2000 Jul; 7(7):1023-33. PubMed ID: 10917205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.
    Trabattoni D; Piconi S; Biasin M; Rizzardini G; Migliorino M; Seminari E; Boasso A; Piacentini L; Villa ML; Maserati R; Clerici M
    AIDS; 2004 Apr; 18(6):859-69. PubMed ID: 15060433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.
    Fan D; Li W; Yang Y; Zhang X; Zhang Q; Yan Y; Yang M; Wang J; Xiong D
    J Hematol Oncol; 2015 Oct; 8():108. PubMed ID: 26444983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.